Projected Income Statement: Neoen

Forecast Balance Sheet: Neoen

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,954 2,375 2,361 2,887 3,015 4,244 5,284 6,229
Change - 21.55% -0.59% 22.28% 4.43% 40.74% 24.51% 17.88%
Announcement Date 25/03/20 11/03/21 14/03/22 01/03/23 28/02/24 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Neoen

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
CAPEX 1 764 529.7 754.5 1,111 1,046 1,121 1,403 1,189
Change - -30.67% 42.44% 47.28% -5.87% 7.13% 25.16% -15.25%
Free Cash Flow (FCF) 1 -579.5 -307.4 -478.5 -654.2 -721.3 -838 -992.7 -486
Change - -46.95% 55.66% 36.72% 10.26% 16.18% 18.46% -51.04%
Announcement Date 25/03/20 11/03/21 14/03/22 01/03/23 28/02/24 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Neoen

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026

Profitability

        
EBITDA Margin (%) 85.35% 90.5% 90.05% 82.27% 90.54% 81% 80.14% 76.96%
EBIT Margin (%) 53.67% 47.66% 51.32% 51.53% 56.2% 48% 49.52% 48.57%
EBT Margin (%) 17.73% 8.3% 16.04% 15.56% 40.35% 20.07% 23.87% 24.21%
Net margin (%) 14.22% 1.31% 12.29% 8.98% 28.64% 13.67% 15.61% 15.52%
FCF margin (%) -228.87% -102.88% -143.44% -130.01% -137.55% -125.16% -111.45% -45.02%
FCF / Net Income (%) -1,609.72% -7,882.05% -1,167.07% -1,447.35% -480.23% -915.55% -714% -290.01%

Profitability

        
ROA 1.21% 0.54% 0.94% 0.81% 2.2% 1.07% 1.43% 1.46%
ROE 5.51% 3.01% 4.1% 2.77% 6.61% 3.55% 4.65% 5.51%

Financial Health

        
Leverage (Debt/EBITDA) 9.04x 8.78x 7.86x 6.97x 6.35x 7.83x 7.4x 7.5x
Debt / Free cash flow -3.37x -7.72x -4.93x -4.41x -4.18x -5.06x -5.32x -12.82x

Capital Intensity

        
CAPEX / Current Assets (%) 301.74% 177.28% 226.17% 220.83% 199.47% 167.36% 157.46% 110.1%
CAPEX / EBITDA (%) 353.54% 195.89% 251.17% 268.41% 220.3% 206.62% 196.49% 143.06%
CAPEX / FCF (%) -131.84% -172.32% -157.68% -169.86% -145.02% -133.71% -141.29% -244.56%

Items per share

        
Cash flow per share 1 2.062 2.348 2.356 3.752 2.255 2.312 3.791 4.593
Change - 13.87% 0.33% 59.23% -39.9% 2.56% 63.93% 21.18%
Dividend per Share 1 - - 0.1 0.125 0.15 0.1629 0.2084 0.2427
Change - - - 25% 20% 8.61% 27.88% 16.5%
Book Value Per Share 1 7.787 7.473 12.98 16.54 17.43 18.03 18.93 19.76
Change - -4.03% 73.71% 27.38% 5.42% 3.43% 4.99% 4.37%
EPS 1 0.41 0.04 0.35 0.37 0.94 0.6 0.9116 1.115
Change - -90.24% 775% 5.71% 154.05% -36.17% 51.93% 22.26%
Nbr of stocks (in thousands) 84,849 85,231 106,858 107,105 151,976 152,660 152,660 152,660
Announcement Date 25/03/20 11/03/21 14/03/22 01/03/23 28/02/24 - - -
1EUR
Estimates
2024 *2025 *
P/E ratio 64.6x 42.5x
PBR 2.15x 2.05x
EV / Sales 15.2x 12.6x
Yield 0.42% 0.54%
More valuation ratios * Estimated data

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
38.74EUR
Average target price
37.15EUR
Spread / Average Target
-4.10%
Consensus

Quarterly revenue - Rate of surprise